John L. Lubniewski
Net Worth
Last updated:
What is John L. Lubniewski net worth?
The estimated net worth of Mr. John L. Lubniewski is at least $5,133,039 as of 4 Apr 2016. He has earned $29,639 from insider trading and has received compensation worth at least $5,103,400 in HTG Molecular Diagnostics, Inc..
What is the salary of John L. Lubniewski?
Mr. John L. Lubniewski salary is $510,340 per year as Pres, Chief Executive Officer & Director in HTG Molecular Diagnostics, Inc..
How old is John L. Lubniewski?
Mr. John L. Lubniewski is 61 years old, born in 1964.
What stocks does John L. Lubniewski currently own?
As insider, Mr. John L. Lubniewski owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| HTG Molecular Diagnostics, Inc. (HTGM) | Pres, Chief Executive Officer & Director | 25,027 | $0 | $0 |
What does HTG Molecular Diagnostics, Inc. do?
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
John L. Lubniewski insider trading
HTG Molecular Diagnostics, Inc.
Mr. John L. Lubniewski has made 6 insider trades between 2015-2016, according to the Form 4 filled with the SEC. Most recently he sold 87 units of HTGM stock worth $254 on 4 Apr 2016.
The largest trade he's ever made was exercising 5,264 units of HTGM stock on 11 Mar 2016. As of 4 Apr 2016 he still owns at least 25,027 units of HTGM stock.
HTG Molecular Diagnostics key executives
HTG Molecular Diagnostics, Inc. executives and other stock owners filed with the SEC:
- Mr. Byron T. Lawson (50) Senior Vice President & Chief Commercial Officer
- Mr. John L. Lubniewski (61) Pres, Chief Executive Officer & Director
- Mr. Shaun D. McMeans (63) Senior Vice President of Fin. & Admin., Chief Financial Officer, Sec. and Treasurer